Walleye Trading’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,928
Closed -$164K 5995
2021
Q2
$164K Buy
3,928
+2,893
+280% +$127K ﹤0.01% 4081
2021
Q1
$50K Buy
+1,035
New +$60.2K ﹤0.01% 4333
2019
Q3
Sell
-1,981
Closed -$154K 4572
2019
Q2
$154K Buy
1,981
+1,371
+225% +$156K ﹤0.01% 3112
2019
Q1
$82K Buy
+610
New +$64.1K ﹤0.01% 3549
2018
Q3
Sell
-1,034
Closed -$103K 5652
2018
Q2
$103K Buy
+1,034
New +$117K ﹤0.01% 4033

Other funds holding CALA

Walleye Trading's CALA Position: Q3 2021 in Review

Walleye Trading sold out of Calithera Biosciences, Inc (CALA) in Q3 2021, closing a stake of 3,928 shares — an estimated $164K sold.

Walleye Trading first reported a position in CALA in Q2 2018 and held it in 5 quarters. The position peaked at $164K in Q2 2021. 66 funds tracked by Wall St. Rank hold CALA as of Q3 2021.

  • Walleye Trading reported no remaining Calithera Biosciences, Inc position as of Q3 2021 after selling out during the quarter.
  • Walleye Trading sold 3,928 Calithera Biosciences, Inc shares in Q3 2021, an estimated $164K.
  • Walleye Trading first reported a position in Calithera Biosciences, Inc in Q2 2018 and held it in 5 quarters.
  • Walleye Trading's Calithera Biosciences, Inc position peaked at $164K in Q2 2021.
  • 66 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2021.

Based on Walleye Trading's 13F filing for Q3 2021, filed 15 Nov 2021.